Your browser doesn't support javascript.
loading
Ultrasound-mediated cavitation enhances the delivery of an EGFR-targeting liposomal formulation designed for chemo-radionuclide therapy.
Thomas, Eloise; Menon, Jyothi U; Owen, Joshua; Skaripa-Koukelli, Irini; Wallington, Sheena; Gray, Michael; Mannaris, Christophoros; Kersemans, Veerle; Allen, Danny; Kinchesh, Paul; Smart, Sean; Carlisle, Robert; Vallis, Katherine A.
Afiliación
  • Thomas E; CRUK/MRC Oxford Institute for Radiation Oncology, Department of Oncology, University of Oxford, Oxford, OX3 7DQ, UK.
  • Menon JU; CRUK/MRC Oxford Institute for Radiation Oncology, Department of Oncology, University of Oxford, Oxford, OX3 7DQ, UK.
  • Owen J; Institute of Biomedical Engineering, Department of Engineering Science, University of Oxford, Oxford, OX3 7DQ, UK.
  • Skaripa-Koukelli I; CRUK/MRC Oxford Institute for Radiation Oncology, Department of Oncology, University of Oxford, Oxford, OX3 7DQ, UK.
  • Wallington S; CRUK/MRC Oxford Institute for Radiation Oncology, Department of Oncology, University of Oxford, Oxford, OX3 7DQ, UK.
  • Gray M; Institute of Biomedical Engineering, Department of Engineering Science, University of Oxford, Oxford, OX3 7DQ, UK.
  • Mannaris C; Institute of Biomedical Engineering, Department of Engineering Science, University of Oxford, Oxford, OX3 7DQ, UK.
  • Kersemans V; CRUK/MRC Oxford Institute for Radiation Oncology, Department of Oncology, University of Oxford, Oxford, OX3 7DQ, UK.
  • Allen D; CRUK/MRC Oxford Institute for Radiation Oncology, Department of Oncology, University of Oxford, Oxford, OX3 7DQ, UK.
  • Kinchesh P; CRUK/MRC Oxford Institute for Radiation Oncology, Department of Oncology, University of Oxford, Oxford, OX3 7DQ, UK.
  • Smart S; CRUK/MRC Oxford Institute for Radiation Oncology, Department of Oncology, University of Oxford, Oxford, OX3 7DQ, UK.
  • Carlisle R; Institute of Biomedical Engineering, Department of Engineering Science, University of Oxford, Oxford, OX3 7DQ, UK.
  • Vallis KA; CRUK/MRC Oxford Institute for Radiation Oncology, Department of Oncology, University of Oxford, Oxford, OX3 7DQ, UK.
Theranostics ; 9(19): 5595-5609, 2019.
Article en En | MEDLINE | ID: mdl-31534505
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Radioisótopos de Indio / Doxorrubicina / Sistemas de Liberación de Medicamentos / Receptores ErbB / Antineoplásicos Tipo de estudio: Evaluation_studies / Prognostic_studies Límite: Animals / Female / Humans Idioma: En Revista: Theranostics Año: 2019 Tipo del documento: Article País de afiliación: Reino Unido Pais de publicación: Australia
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Radioisótopos de Indio / Doxorrubicina / Sistemas de Liberación de Medicamentos / Receptores ErbB / Antineoplásicos Tipo de estudio: Evaluation_studies / Prognostic_studies Límite: Animals / Female / Humans Idioma: En Revista: Theranostics Año: 2019 Tipo del documento: Article País de afiliación: Reino Unido Pais de publicación: Australia